Nelson memo

The Nelson Memo: Igniting a Global Open Data Revolution

The landscape of scientific research is undergoing a seismic shift, driven by an urgent demand for transparency, reproducibility, and equitable access. At the epicenter of this transformation in the United States is the Nelson Memo, a policy directive rapidly accelerating the future of open science. With the National Institutes of Health (NIH)'s recent announcement (NOT-OD-25-101)…...
Read More

Top Stories

MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging...
Rare diseases

Rare Diseases – An Evolving Medical Communications Landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
Health Literacy Month

Celebrating Health Literacy Month 2024: Strengthening Biopharma-Patient Connections

October is Health Literacy Month, a reminder of the importance of clear communication in healthcare...
world patient safety day

Celebrating World Patient Safety Day 2024: Improving Diagnosis for a Safer Tomorrow

On World Patient Safety Day 2024, we focus on the critical theme of "Improving Diagnosis...

Transforming Scientific Content with Microsoft 365 Copilot: Cactus Life Sciences in the Spotlight

We are thrilled to announce that Cactus Life Sciences has been featured in Microsoft Stories...
Empowering Medical Affairs by Leveraging Modular Content

Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content

In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...

Learn more ABOUT our company.